The TP53 gene sequence is commonly altered in breast cancer (Bertheau et al, 2013; Dumay et al, 2013), and this point mutation represents an established pathogenic variant (Fig EV3A–C) (Xu et al, 1997; Oh et al, 2000). This evidence concerns the gene TP53 and breast carcinoma.